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ABSTRACT
Objective: To investigate the anticancer and anti-inflammatory potential of chia seed oil (CSO) and its blends in vitro.
Methods: The in vitro cancer cytotoxic properties ability of CSO and its blends was evaluated by (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) (MTT) and trypan blue assays using major cell lines including chronic myelogenous leukemia, HeLa and MCF-7 cells. The anti-inflammatory 
effect of the CSO and its blends was studied by assessing the anti-lipoxygenase (LOX) activity in vitro.
Results: Incubation with CSO alone significantly inhibited the LOX activity. In the combination groups, CSO slightly increased the inhibition among 
blends of soybean and palmolein oils. In addition, CSO alone and in blends demonstrated potent and differential anticancer activity in MTT and trypan 
blue assays.
Conclusion: Our results pave the way for the conclusion that CSO alone or in combination with the vegetable oils proves to be a healthy synergistic 
supplement or an adjuvant for the current diet. The supplementation with CSO is suggested for the modern lifestyle to delay or prevent the incidence 
of degenerative disorders.
Keywords: Salvia hispanica, Trypan blue, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), Inflammatory.
INTRODUCTION
Unmitigated increase in the incidence of cancer and the incomplete 
success with the chemotherapy has presented the lookout for an 
effective but safer anticancer drug. The past decades have assessed the 
dietary role for modern diseases and indicated a strong relationship 
between the diet and the ailment via both population studies and 
experimental reports. Specific dietary designs have been proposed for 
various ailments among different human communities. Hence, different 
sources for the known dietary principles have been hunted for in the 
recent past which provides an economic and efficient supply of the 
same [1,2].
Although plenty of drugs were explored for cancer treatment, the 
clinical relevance of drug development for a routine practice remains 
distant due to the high costs and side effects. Inflammation dictates 
the initiation and progression. The n-3 fatty acids demonstrate anti-
inflammatory effects in vivo. However, there is a limitation of data 
about the cancer preventive role of fatty acids however they have 
been demonstrated to preserve the muscle mass and function in 
chemotherapeutic subjects [3]. The n-3 fatty acids like eicosapentaenoic 
acid and docosahexaenoic acids have been found to reduce the risk of 
breast cancer [4]. A new concept of a combination of chemotherapy and 
nutrition therapy is emerging.
Polyunsaturated fatty acids have been claimed to enhance the 
membrane dynamics. Hence, the concentration of the former is usually 
associated with the mitochondrial function. Several reports suggest 
a strong anticancer property for polyunsaturated fatty acid (PUFA) 
in vivo and in vitro [5]. Accordingly, we selected chia (Salvia hispanica) 
a vegetarian PUFA source and set out to study its biological properties 
using the accepted in vitro models.
In this line of research, various plant products and their derivatives 
have been screened for their biological activities including anticancer 
properties [6-21]. We have reported the chemical constituents and fatty 
acid profile of chia seed oil (CSO). Further, we also assessed antidiabetic, 
antioxidant, and anti-inflammatory properties of CSO alone and in 
blend with the major vegetable oils. Our studies were suggestive that 
CSO reduces the preliminary complications of diabetes as well as 
reduces the proinflammatory reactions [8,9]. Hence, our hypothesis is 
that owing to the major biological properties; chia seed can be a potent 
anticancer agent. We estimated the cancer cytotoxic properties of CSO 
and its blends with the major vegetable oils among the major cancer 
cell lines for testing the hypothesis.
MATERIALS AND METHODS
Materials
Seeds of chia (S. hispanica L.) were procured locally from Heggadadevana 
Kote, Mysuru, Karnataka, India. The sample was authenticated by the 
Department of Studies in Botany, Manasagangotri, Mysuru. The seeds 
were cleaned to get rid of impurities/damaged seeds; stored at 4°C. The 
sound seeds were powdered, and the oil was extracted [9] and used for 
the analysis. The selected vegetable oils such as sunflower oil (SFO), 
olive oil (OlO), palmolein oil (PO), and soybean oil (SO) were purchased 
from local market in Mysuru city, Karnataka.
Chemicals and reagents
All solvents, chemicals, and drugs used in the studies were of analytical 
grade and purchased from SDFCL, Mumbai, India. Tris buffer, linoleic 
acid was purchased from SRL, India.
Sample preparation
The blends were prepared using raw CSO with selected vegetable oils, 
namely, PO, soybean, and OlO. These blends were prepared by placing 
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them in a test tube in the desired ratio and mixing in a cyclomixer for 
15 minutes at room temperature. The oil blends were screened for 
the biological activities immediately. The mixtures of oil samples of 
different concentrations S1-S14 (10-40 µl/ml) were prepared in DMSO 
(10%) and sample preparation was as following: Sample 1-(SFO), 
Sample 2-(CSO), Sample 3-(OlO), Sample 4-(PO), Sample 5-(SO), Sample 
6-(CSO: OlO [75:25]), Sample 7-(CSO: OlO [50:50]), Sample 8-(CSO: OlO 
[25:75]), Sample 9-(CSO: PO [75:25]), Sample 10-(CSO: PO [50:50]), 
Sample 11-(CSO: PO [25:75]), Sample 12-(CSO: PO [75:25]), Sample 13-
(CSO: SO [50:50]), and Sample 14-(CSO: SO [25:75]).
Cell lines and culture
Human chronic myelogenous cell lines (CM cells), MCF-7 (human breast 
tumour), and HeLa (human cervical cancer) obtained from the National 
Centre for Cell Science, Pune, India. Cells were grown in RPM1 1640 
supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml 
of penicillin and 100 µg of streptomycin/ml and incubated at 37°C in a 
humidified atmosphere with 5% CO2. The standard drugs used for the 
cells are CM cells - abitrexate; MCF-7 – tamoxifen, and HeLa – avastin.
Methods
In vitro anti-lipoxygenase (LOX) activity
LOX enzyme was prepared as a crude extract from pre-soaked soybeans 
by homogenizing in phosphate buffer, pH 6.8 for 20 minutes at 4°C and 
centrifuged at 10,000 rpm for 10 minutes at 4°C and supernatant was 
used [18]. Aliquots of crude LOX extract were incubated for 5 minutes 
(in 50 mM Tris buffer, pH 7.4) with oil samples in triplicates at different 
concentrations (10, 20, and 40 µl). Simultaneously, separate aliquots 
of enzyme were incubated with indomethacin (standard) and the oil 
samples. The enzyme reaction was started by adding 1 ml of linoleic 
acid (50 μM). Increase in absorbance was recorded at 234 nm using a 
spectrophotometer against buffer blank. One unit of enzyme was taken 
as equivalent to the amount of enzyme that generated an increase in 
absorbance of 1.0 per minutes at 234 nm.
In vitro anticancer studies
3-(4, 5 dimethyl-2-yl)-2,5 diphenyl tetrazolium bromide (MTT) assay
The cytotoxic effects of the different oil samples (S1-S14) were 
assessed against the CM leukemic cells (5×105 cells) using MTT 
assay [19]. The test samples are dissolved in DMSO and treated with 
different concentrations of oil samples (10, 20, and 40 µl). Cells in the 
control wells received the same volume of medium containing DMSO. 
After 48 hrs treatment, cells were harvested and incubated with MTT 
(0.5 µg/ml) for 4 hrs at 37°C in 96 well plate. The blue MTT formazan 
precipitate formed in the viable cells is solubilized by the addition of 
70 µl DMSO. The suspension is placed in micro vibrator for 5 minutes, 
and absorbance was measured at 540 nm using a multimode reader 
(Varioskan Flash Multimode, Thermo Scientific, USA). The experiment 
was performed in triplicate and repeated at least for 3 times. IC50 
concentration for each oil sample using the Prism software.
Trypan blue exclusion assay
To study the growth suppressive effects of the oil samples (S1-S14), 
0.5×105 cells/ml were plated in a 24 well plate (Corning, USA.) in 
1 ml of complete medium [19]. The cells were treated with various 
concentrations of the oil samples (10, 20, and 40 µl/ml). DMSO treated 
cells were used as a control. Cells were harvested after 48 hr and stained 
with 0.4% trypan blue and calculated using a hemocytometer for viable 
cells. Experiments were done in triplicates, and the percentage of 
growth inhibition by different samples at different concentrations was 
plotted against time (48 hr).
Statistical analyses
The data obtained were analyzed by one-way ANOVA followed by 
Tukey’s post-hoc analyses using the Graphpad software prism 5.1 
and Excel software at constant p≤0.05. The data were expressed as a 
mean±standard deviation, and all experiments were compared with 
control and performed in triplicates.
RESULTS AND DISCUSSION
Many experimental evidence suggests that inflammatory pathways 
predominate the pathophysiology of major metabolic syndromes 
such as diabetes and cardiovascular diseases (CVD). It has been 
noted that obesity and comorbidities such as diabetes and CVD are 
resulted from chronic, low-grade inflammation impacting multiple 
organ systems [22]. The compromised inflammatory state is usually 
attributed to higher levels of proinflammatory signaling from 
adipocytes. Dietary intervention studies have indicated that n-3 PUFA 
rich diet alleviates the metabolic syndromes through attenuating the 
inflammatory status of the system [23,24]. Hence, it was interesting 
to study the anti-inflammatory properties of Indian chia seeds in an 
in vitro setup. Even though chia is not used as a major food component 
in today’s diet globally, owing to the high content of alpha linolenic 
acid (ALA), chia is speculated to become an excellent dietary adjuvant 
shortly. Hence, in this study, we fortified chia oil with the other major 
edible vegetable oils such as PO, OlO, and SO for the anti-inflammatory 
assays. It was assumed that fortification with the other edible oils may 
replicate the changes in the beneficial effects of CSO when it is used 
in association with the regular diet [25]. Fortification with the other 
vegetable oils is a mandatory method of activity assessment in case 
of not so frequently used food products like chia since this method 
reveals the complementary effects of these dietary components [26]. 
In this study, we examined the anti-inflammatory property of CSO 
per se and in synergy with the other vegetable oils employing in vitro 
LOX assay.
In vitro anti-LOX activity
The anti-inflammatory property of CSO was assessed by estimating 
inhibition of LOX activity in vitro (Fig. 1). Enzymes like LOX 
actively participate in the inflammatory reactions in vivo. These are 
autocatalytic enzymes which are activated by numerous factors. 
Therefore, studying the inhibitory effects on LOX reveal a better 
picture of the biological activity of the oil blends. For this purpose, the 
crude extract of LOX was prepared from soybeans. Incubation with 
CSO alone significantly inhibited the LOX activity in a concentration-
dependent manner (up to 63%). The LOX inhibitory properties of the 
other oils individually were not different than that of CSO. However, 
in combination groups, CSO slightly increased the inhibition among 
blends of soybean and PO.
Previous reports suggest that blending of different oils resulted in 
better storage and improved antioxidant properties in vitro [27]. 
Moreover, health benefits from functional foods as chia seeds are usually 
conspicuous on a chronic supplementation. The results of our study are 
in contrast with a few reports about anti-inflammatory properties of 
ALA and CSO among in vivo systems.
Fig. 1: Effects of oil samples on the activity of lipoxygenase in vitro. 
Values are mean±standard deviation (n=3 replications for each 
sample and concentration) analyzed by one-way ANOVA followed 
by post -hoc Tukey’s test. Data are pooled from three independent 
experiments (*, # and $ indicate significant difference at p≤0.05)
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In vitro anticancer property against CM leukemic cells
MTT is a most accepted assay to estimate the viability of the cells 
in vitro [28]. Among all the oil samples tested for anticancer effect, chia 
oil demonstrated highest cytotoxic efficacy (up to 90%) followed by olive 
and SOs (Fig. 2) against the human CM cells. The IC50 of CSO was 5.32 µl 
(Table 1) which was slightly increased in the blends of palmolein and SOs 
(up to 12.07 µl). Although comparatively the cytotoxic effects of PO was 
marginally lesser when compared to other oil samples, but in combination 
with CSO, the cytotoxic property was enhanced. Similar results were 
observed among SO alone and blend with chia oil. Contrast to MTT assay, 
in trypan blue assay; the oil samples demonstrated a slightly different 
trend of anticancer activity (Fig. 3). Based on trypan blue assay, CSO alone 
inhibited CM cells proliferation significantly (up to 67%), and this effect 
was similar to OlO alone. Palmolein and SOs individually did not affect 
the cancer cells. However, CSO in blending with PO and SO the anticancer 
activity was observed up to 50%. As evidenced from the data, the enhanced 
anticancer activity among these blends is totally owed to CSO.
In vitro anticancer property against HeLa cells
Further, the cytotoxic property of CSO alone and in combinations was 
assessed in HeLa cells also. HeLa cells are the human cervical cancer 
cells and are typical of their kind. HeLa cells are the oldest used human-
derived cancer cells for the research purpose. These cells are widely 
employed to assess the anticancer activity of possible potential drug 
compounds [29]. In addition, these cells are also employed to study the 
mechanistic pathways of those active principles. As anticipated, CSO 
per se significantly inhibited proliferation of HeLa cells as evidenced by 
the MTT assay (Fig. 4). The IC50 of CSO was 11.46 µl (Table 1). Interestingly, 
the cytotoxic effects were similarly significant in combination groups 
with OlO, however, was not up to the extent of CSO alone. Further, 
though individually palmolein and SO did not demonstrate anticancer 
activity, but in combination with CSO, they showed significant inhibition 
of cancer cell proliferation. The IC50 concentration of olive, palmolein 
and SOs individually were 72.46, 167.79, and 126.26 µl, however, 
the values decreased significantly in combination with the chia oil in 
their blends and were 18.7, 30.3, and 24.18, respectively (Table 1). In 
addition, the trypan blue assay confirmed the results obtained in MTT 
assay. In trypan blue assay, CSO alone inhibited HeLa cell proliferation 
significantly (Fig. 5). In combination, chia oil enhanced the activity 
of palmolein and SO marginally. Evidently, the results obtained from 
trypan blue assay were similar to that of MTT assay.
In vitro anticancer property against MCF-7 cells
The anticancer activity of CSO was confirmed using the breast cancer 
cells, namely, MCF-7. The MCF-7 breast cancer cells represent the 
metastatic cells with the highest virulence and are experimentally 
Table 1: IC50 concentrations of oil samples (µl) and standard 
drug compounds (ng) calculated from the MTT assay among the 
cancer lines
Samples CM cells HeLa cells MCF-7 cells
Sample 1 9.90±0.10 15.06±0.15 31.53±0.32
Sample 2 5.32±0.05 11.46±0.11 17.24±0.17
Sample 3 9.71±0.10 72.46±0.72 103.00±2.41
Sample 4 49.50±0.50 167.79±0.68 510.00±5.00
Sample 5 13.75±0.14 126.26±1.26 252.00±2.50
Sample 6 5.56±0.06 18.70±0.19 64.94±0.65
Sample 7 11.51±0.12 20.33±0.20 110.00±1.00
Sample 8 12.07±0.12 23.35±0.23 511.00±5.00
Sample 9 5.82±0.06 30.30±0.30 33.78±0.34
Sample 10 5.82±0.06 61.32±0.61 79.62±0.80
Sample 11 11.11±0.11 126.26±1.26 257.00±2.50
Sample 12 6.35±0.06 24.18±0.24 26.23±0.26
Sample 13 6.04±0.06 39.23±0.39 45.60±0.46
Sample 14 15.63±0.16 57.06±0.57 72.46±0.72
Standard 
drug
10.42±0.10 (ng) 10.20±0.10 (ng) 10.31±0.10 (ng)
Values are mean±SD (calculated from three independent 
experiments using the Prism software). SD: Standard deviation, 
MTT: (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), 
CM: Chronic myelogenous
Fig. 2: Effects of oil samples against viability (or proliferation) 
of human chronic myelogenous leukemic cells in vitro (48 hr 
exposure). Values are mean±standard deviation (n=3 replications 
for each sample and concentration) analyzed by one-way 
ANOVA followed by post-hoc Tukey’s test. Data are pooled from 
three independent experiments (*, # and $ indicate significant 
difference at p≤0.05)
Fig. 3: Effects of oil samples against human chronic myelogenous 
leukemic cells in vitro (trypan blue exclusion method). Values 
are mean±standard deviation (n=3 replications for each sample 
and concentration) analyzed by one-way ANOVA followed by 
post-hoc Tukey’s test. Data are pooled from three independent 
experiments (*, # and $ indicate significant difference at p≤0.05)
Fig. 4: In vitro anticancer effects of oil samples against HeLa 
cells (48 hr exposure). Values are mean±standard deviation 
(n=3 replications for each sample and concentration) analyzed 
by one-way ANOVA followed by post-hoc Tukey’s test. Data are 
pooled from three independent experiments (*, # and $ indicate 
significant difference at p≤0.05)
127
Asian J Pharm Clin Res, Vol 10, Issue 10, 2017, 124-128
 Gazem et al. 
exploited to study the mechanism of action of the drug candidates [29]. 
There was a significant and concentration-dependent inhibition of 
cancer proliferation among cells exposed to CSO per se (Fig. 6). The 
protective effects were significant in OlO combination groups (with 
75% chia oil). Individually palmolein and SO did not show protective 
efficacy. However, in combination groups, there was a slight anticancer 
activity among palmolein+chia and SO+chia oil. The IC50 of CSO was 
17.24 µl (Table 1). The IC50 concentration of olive, palmolein and SOs 
individually were 103, 510, and 252µl, however, the values decreased 
significantly in combination with the chia oil in their blends and were 
64.94, 33.78, and 26.23, respectively (Table 1). Further, in the trypan 
blue assay in MCF-7 cells, CSO alone showed the highest inhibition 
of proliferation (up to 47%) (Fig. 7). The antiproliferation activity of 
OlO alone was not changed in combination with chia oil. However, the 
protective activity of PO was enhanced in combination with CSO (up to 
39%). In totality, the anticancer property of chia oil and its blending 
with vegetable oils suggest a potent therapeutic role as a functional 
food for chia in the futuristic dietary approach.
Dietary PUFAs have been attributed numerous health benefits if 
consumed on a regular basis. Scientific reports strongly suggest the 
beneficial effects of chia on human health owing to its high PUFA 
content. Interestingly in an isolated study, feeding hens with chia 
resulted in eggs with highest ALA content when compared to hens fed 
with linseed or rapeseed [30]. In addition, rats fed on chia seed rich 
diet demonstrated a decrease in low-density lipoprotein and serum 
triglycerides, in contrast, high-density lipoprotein and n-3 PUFA levels 
were elevated [31]. It was also observed that no adverse effects were 
observed on the rat’s thymus and IgE serum level. In a similar study, 
pigs and rabbits fed with chia seeds resulted in an increased of PUFA 
content, flavor and aroma in the meat fats [32]. At present, a major 
part of dietary PUFA is obtained from marine sources. However, the 
psychological stigma of people about biomagnification of some heavy 
metals and pesticides in addition to the disapproving odor, hinder 
them from consuming the fish based supplements. Moreover, a typical 
organoleptic characteristic such as flavor and smell from marine 
sources were not found in chia making it a desirable vegetable source 
for PUFA since ALA is converted enzymatically to PUFA in vivo [31]. In 
addition, global conscience about the vegetarian diet has compelled 
the food industry to watch out for vegetable sources of the n-3 PUFA. 
Thus, the excellent biological activities prove a better market presence 
for chia and make chia a prime candidate as a health supplement for 
improving the food quality.
Our study clearly demonstrates the potent anticancer property of CSO 
as estimated with reduced MTT reduction among CM leukemia, HeLa, 
and MCF-7 cells. In addition, the anti-inflammatory property of CSO and 
its blends was confirmed with the inhibition of LOX in vitro. Our results 
provide evidence that CSO alone or in combination with the vegetable 
oils proves to be a healthy synergistic supplement or an adjuvant for 
this diet. The supplementation with CSO is suggested for the modern 
lifestyle and the unhealthy diet to delay or prevent the incidence of 
degenerative disorders among humans.
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